| Literature DB >> 32978771 |
Saleh Jamehdor1,2,3, Kasra Arbabi Zaboli4, Sina Naserian5,6, Jose Thekkiniath7, Honey Alef Omidy8, Ali Teimoori1, Behrooz Johari4, Amir Hossein Taromchi4, Yu Sasano9, Saeed Kaboli4.
Abstract
Clustered Regulatory Interspaced Short Palindromic Repeats (CRISPR) is one of the major genome editing systems and allows changing DNA levels of an organism. Among several CRISPR categories, the CRISPR-Cas9 system has shown a remarkable progression rate over its lifetime. Recently, other tools including CRISPR-Cas12 and CRISPR-Cas13 have been introduced. CRISPR-Cas9 system has played a key role in the industrial cell factory's production and improved our understanding of genome function. Additionally, this system has been used as one of the major genome editing systems for the diagnosis and treatment of several infectious and non-infectious diseases. In this review, we discuss CRISPR biology, its versatility, and its application in biomedical engineering.Entities:
Keywords: CRISPR-Cas12; CRISPR-Cas13; CRISPR-Cas9; Genome editing; sgRNA
Mesh:
Year: 2020 PMID: 32978771 DOI: 10.5603/FHC.a2020.0023
Source DB: PubMed Journal: Folia Histochem Cytobiol ISSN: 0239-8508 Impact factor: 1.698